ストックスクリーナーアプリを入手
12.72
5.43%
-0.73
アフターアワーズ：
12.72
前日終値:
$13.45
開ける：
$13.25
24時間の取引高:
31,853
Relative Volume:
0.43
時価総額：
$244.37M
収益：
$54,000
当期純損益:
$-210.26M
株価収益率:
-16.10
EPS:
-0.79
ネットキャッシュフロー:
$-159.01M
1週間 パフォーマンス:
+0.63%
1か月 パフォーマンス:
+15.95%
6か月 パフォーマンス:
+21.10%
1年 パフォーマンス:
-52.89%
1日の値動き範囲:
$12.72
$13.25
1週間の範囲:
$12.70
$13.75
52週間の値動き範囲:
$7.65
$32.00
Lyell Immunopharma Inc Stock (LYEL) Company Profile
名前
Lyell Immunopharma Inc
セクター
電話
650 695-0677
住所
201 HASKINS WAY, SOUTH SAN FRANCISCO
LYEL を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
LYEL
Lyell Immunopharma Inc
|
12.72 | 258.39M | 54,000 | -210.26M | -159.01M | -0.79 |
|
VRTX
Vertex Pharmaceuticals Inc
|
381.87 | 96.56B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
449.58 | 60.08B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
555.51 | 61.15B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
711.09 | 44.66B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
328.71 | 36.23B | 3.81B | -644.79M | -669.77M | -6.24 |
Lyell Immunopharma Inc Stock (LYEL) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2024-10-30 | ダウングレード | BofA Securities | Buy → Underperform |
| 2024-06-27 | ダウングレード | H.C. Wainwright | Buy → Neutral |
| 2023-08-28 | ダウングレード | JP Morgan | Overweight → Neutral |
| 2022-11-14 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
| 2022-11-11 | ダウングレード | Goldman | Buy → Neutral |
| 2022-10-17 | 開始されました | H.C. Wainwright | Buy |
| 2021-07-12 | 開始されました | BofA Securities | Buy |
| 2021-07-12 | 開始されました | Goldman | Buy |
| 2021-07-12 | 開始されました | JP Morgan | Overweight |
| 2021-07-12 | 開始されました | Morgan Stanley | Overweight |
すべてを表示
Lyell Immunopharma Inc (LYEL) 最新ニュース
Can trapped investors hope for a rebound in Lyell Immunopharma Inc.Weekly Earnings Recap & Weekly Return Optimization Alerts - newser.com
Technical analysis overview for Lyell Immunopharma Inc. stock2025 Support & Resistance & Fast Entry Momentum Trade Alerts - newser.com
Using Ichimoku Cloud for Lyell Immunopharma Inc. technicalsJuly 2025 Weekly Recap & Advanced Swing Trade Entry Plans - newser.com
Applying chart zones and confluence areas to Lyell Immunopharma Inc.2025 Stock Rankings & AI Enhanced Execution Alerts - newser.com
How moving averages guide Lyell Immunopharma Inc. tradingWeekly Profit Report & Daily Volume Surge Trade Alerts - newser.com
Can Lyell Immunopharma Inc. rally from current levelsInsider Buying & Advanced Swing Trade Entry Plans - newser.com
Applying Elliott Wave Theory to Lyell Immunopharma Inc.2025 Momentum Check & Expert Curated Trade Ideas - newser.com
Smart tools for monitoring Lyell Immunopharma Inc.’s price actionJuly 2025 PreEarnings & Scalable Portfolio Growth Ideas - newser.com
Applying Wyckoff theory to Lyell Immunopharma Inc. stockJobs Report & High Return Trade Guides - newser.com
Comparing Lyell Immunopharma Inc. in custom built stock radarsWatch List & Community Verified Swing Trade Signals - newser.com
Can swing trading help recover from Lyell Immunopharma Inc. lossesWeekly Investment Report & Growth Oriented Trading Recommendations - newser.com
Has Lyell Immunopharma Inc. found a price floorWeekly Investment Summary & Low Risk Entry Point Guides - newser.com
price momentum metrics for lyell immunopharma inc. explainedChart Signals & Reliable Entry Point Alerts - newser.com
Price momentum metrics for Lyell Immunopharma Inc. explained2025 EndofYear Setup & Step-by-Step Swing Trade Plans - newser.com
Trend analysis for Lyell Immunopharma Inc. this weekWeekly Profit Recap & Reliable Volume Spike Alerts - newser.com
Levels Update: Is Lyell Immunopharma Inc stock trending bullishWeekly Profit Report & Daily Profit Focused Screening - khodrobank.com
Is Lyell Immunopharma Inc. forming a bottoming baseJuly 2025 Levels & Verified Chart Pattern Signals - newser.com
Is it time to cut losses on Lyell Immunopharma Inc.July 2025 Chart Watch & Daily Profit Maximizing Trade Tips - newser.com
Tools to monitor Lyell Immunopharma Inc. recovery probabilityPortfolio Return Report & Real-Time Buy Zone Alerts - newser.com
Using fundamentals and technicals on Lyell Immunopharma Inc.Market Sentiment Report & Daily Profit Focused Screening - newser.com
News impact scoring models applied to Lyell Immunopharma Inc.July 2025 Catalysts & Weekly Breakout Stock Alerts - newser.com
Combining price and volume data for Lyell Immunopharma Inc.Trade Volume Summary & High Conviction Buy Zone Alerts - newser.com
S P Trends: Can Amaze Holdings Inc. continue delivering strong returns2025 EndofYear Setup & Free Community Consensus Stock Picks - خودرو بانک
Stop Loss: What is the long term forecast for Lyell Immunopharma Inc stock2025 Risk Factors & Verified Short-Term Trading Plans - خودرو بانک
Market Outlook: Can Lyell Immunopharma Inc expand its profit marginsJuly 2025 PreEarnings & AI Driven Price Forecasts - خودرو بانک
Will Lyell Immunopharma Inc. benefit from green energy policies2025 Support & Resistance & Weekly Watchlist for Hot Stocks - خودرو بانک
Charles Newton resigns as CFO of Lyell ImmunopharmaSEC filing - MarketScreener
Aug Breakouts: Is ProShares Trust ProShares Ultra Nasdaq Biotechnology stock a smart retirement pickPortfolio Update Summary & Stock Portfolio Risk Management - خودرو بانک
MACD Signal: Can Lyell Immunopharma Inc expand its profit margins2025 Institutional Moves & AI Driven Stock Movement Reports - khodrobank.com
Lyell Immunopharma Inc. stock volume spike explained2025 Fundamental Recap & Smart Allocation Stock Tips - newser.com
Should you hold or exit Lyell Immunopharma Inc. now2025 Big Picture & Daily Stock Trend Watchlist - newser.com
Stop Loss: What is LEDSs book value per sharePortfolio Return Report & Reliable Entry Point Alerts - khodrobank.com
Moving Averages: Can Lyell Immunopharma Inc. reach all time highs this year2025 Key Highlights & Risk Adjusted Swing Trade Ideas - خودرو بانک
What’s the recovery path for long term holders of Lyell Immunopharma Inc.2025 Market WrapUp & Long-Term Capital Growth Strategies - newser.com
Lyell Immunopharma Inc (LYEL) 財務データ
収益
当期純利益
現金流量
EPS
2.43%
大文字化:
|
ボリューム (24 時間):